GMAB Non-viral, Cell-penetrating Gene Monoclonal Antibody Platform: A Highly Targeted and Unique Approach for Delivery of Therapeutic Nucleic Acids

Time: 11:30 am
day: Track B - Day 2 AM


  • Non-covalent binding and protection of both RNA and DNA payloads
  • Selective targeting of ENT2 transporter and cell penetration into cytoplasm and nucleus
  • Systemic delivery of nucleic acid payloads to ENT2 positive tissues in vivo
  • Optionality for therapeutic nucleic acid targeting in treatment of cancer and musculoskeletal disease